On April 24, 2019 Precision BioSciences (Nasdaq: DTIL) ("Precision"), a genome editing company dedicated to improving life (DTIL) through its proprietary ARCUS genome editing platform, reported its participation in several preclinical presentations and a Genome Editing Workshop presentation at the 22nd Annual Meeting of the American Society of Gene & Cell Therapy ("ASGCT") to be held in Washington, DC, April 29 – May 2, 2019 (Press release, Precision Biosciences, APR 24, 2019, View Source [SID1234535377]).
Schedule your 30 min Free 1stOncology Demo!
Discover why more than 1,500 members use 1stOncology™ to excel in:
Early/Late Stage Pipeline Development - Target Scouting - Clinical Biomarkers - Indication Selection & Expansion - BD&L Contacts - Conference Reports - Combinatorial Drug Settings - Companion Diagnostics - Drug Repositioning - First-in-class Analysis - Competitive Analysis - Deals & Licensing
Schedule Your 30 min Free Demo!
Precision BioSciences Presentations:
Title: Genome Editing Workshop Presentation; Precision BioSciences Chief Scientific Officer Derek Jantz, Ph.D., will speak during the Corporate Review I session.
Session: 1:00-2:00 PM ET, Sunday, April 28 – Jefferson East
Title: A Gene Editing Approach to Eliminate Hepatitis B Virus In Vivo with an ARCUS Meganuclease Evolved to Prevent Off Target Cutting
Session: 5:00-6:00 PM ET, Tuesday, April 30 – Board no. 75
Title: Therapeutic Efficacy of ARCUS Meganuclease Gene Editing for Autosomal Dominant Retinitis Pigmentosa
Session: 10:15-10:30 AM ET, Thursday, May 2 – Jefferson
Presentations from Precision Collaborators:
Title: Gene Editing Approach to Disrupt Hydroxyacid Oxidase 1 for the Treatment of Primary Hyperoxaluria Type 1
Session: 10:30-10:45 AM, ET, Thursday, May 2 – Heights Courtyard 3
Title: Reduction of Transthyretin Expression by AAV Gene Delivery of a Novel Endonuclease in Mice
Session: 11:00-11:15 AM, ET, Thursday, May 2 – Heights Courtyard 3
Abstracts are available on the ASGCT (Free ASGCT Whitepaper) meeting website.